MedTrace Logo

The Tobramycin Study

NCT00257790 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2011-07-06

No results posted yet for this study

Summary

Evaluate if tobramycin given once a day is at least as efficacious as the traditional tobramycin given three times a day, given with penicillin G, til patients with febrile neutropenia.

Conditions

Interventions

DRUG

Tobramycin once a day

Sponsors & Collaborators

  • The National Institute of Health, Oslo

    collaborator UNKNOWN

  • Ullevaal University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Sykehuset Buskerud

    collaborator UNKNOWN

  • Sentralsjukehuset i Rogaland

    collaborator UNKNOWN

  • Sykehuset Innlandet HF

    collaborator OTHER

  • Sentralsjukehuset i Hedemark

    collaborator UNKNOWN

  • The Hospital of Vestfold

    collaborator OTHER

  • Sykehuset Asker og Baerum

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Dag Torfoss, MD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Completion
2005-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00257790 on ClinicalTrials.gov